Rosetta Genomics Unveils Two New Development-Stage Tests
September 09, 2010
Rosetta Genomics Unveils Two New Development-Stage Tests
The company also disclosed that its dispute with the US distributor of its three commercialized diagnostics, Prometheus Laboratories, is set to go before an arbitration panel shortly.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.